Preimplantation Genetic Diagnosis Market (Test Type - PGD for Chromosomal Aberrations, Aneuploidy Screening, Gender Selection, Single Gene Disorders, HLA Typing & X-linked Diseases)
6/17/2015 06:49:00 PMSince the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader range of indications due to advancements in the medical technology. These indications include chromosomal aberrations, genetic abnormalities, gender selection, HLA typing, X-linked diseases and single gene diseases. Demand for PGD is continuously increasing in patients who undergo IVF in the hope that it would improve the probability of live birth and reduce the chances of disabilities and genetic disorders in the offspring.
This report provides in-depth analysis of the preimplantation genetic diagnosis market and its test types across various regions. Stakeholders in the report include diagnostic laboratories that provide PGD services, companies involved in the production of diagnosis kits and sequencers for PGD, and prospective market players planning to enter the market. The report comprises executive summary, which offers a market snapshot that covers the overall information about various types of tests in the PGD market.
The market overview section explains market dynamics such as drivers, restraints and opportunities that influence the current and future status of the preimplantation genetic diagnosis market. Impact factors such as market attractiveness analysis and regulatory framework of PGD in various countries has been included in this section in order to provide a thorough analysis of the overall competitive scenario of the global preimplantation genetic diagnosis market. The report covers competitive analysis, which includes heat map analysis by key market players. Through heat map analysis, the stakeholder would be able to identify the presence of players across various segments of the market. All these factors would help market players gain a thorough understanding of the overall competitive scenario. The market players can then decide upon the business strategies and plans to be implemented in order to strengthen their position in the global market.
The global preimplantation genetic diagnosis market has been differentiated based on the types of tests and geographies. Based on the types of tests, the global preimplantation genetic diagnosis market has been segmented into six categories: PGD for chromosomal aberrations, aneuploidy screening, X-linked diseases, single gene disorder, HLA typing and gender selection. A detailed market analysis of the segments mentioned above has been provided at the global level in this study. The market analysis is based on market size and forecast in terms of USD million for the period 2013 to 2020 along with the compounded annual growth rate (CAGR %) for the period 2014 to 2020, considering 2013 as the base year.
Geographically, the global preimplantation genetic diagnosis market has been categorized into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section further provides market size and forecast for various types of PFD tests in each region. The market size and forecast of the regional markets is provided for the period 2012 to 2020. CAGR (%) for each region is also estimated for the period 2014 to 2020, considering 2013 as the base year. The report also includes strategic recommendations, which would help market players sustain and grow in the highly competitive market. These recommendations would also help new entrants establish a strong position in the global preimplantation genetic diagnosis market.
Company profiles section comprises key information such as company overview, financial overview, product portfolio, business strategies and recent developments about major players operating in the preimplantation genetic diagnosis market. Key players profiled in the report include Genesis Genetics, Genea Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Reprogenetics LLC and Reproductive Genetics Institute.
The global preimplantation genetic diagnosis market is segmented into the following categories:Preimplantation Genetic Diagnosis Market, by Test Type
PGD for Chromosomal Aberrations
PGD for Aneuploidy Screening
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases
Preimplantation Genetic Diagnosis Market, by Geography
North America
PGD for Chromosomal Aberrations
PGD for Aneuploidy Screening
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases
Europe
PGD for Chromosomal Aberration
PGD for Aneuploidy Screening
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases
Asia Pacific
PGD for Chromosomal Aberrations
PGD for Aneuploidy Screening
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases
Rest of the World (RoW)
PGD for Chromosomal Aberrations
PGD for Aneuploidy Screenin
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases
Original source: http://www.marketwatch.com/story/preimplantation-genetic-diagnosis-market-test-type---pgd-for-chromosomal-aberrations-aneuploidy-screening-gender-selection-single-gene-disorders-hla-typing-x-linked-diseases---global-industry-analysis-size-share-growth-trends-forecast-2014-2015-06-16
IVF in Stork Fertility Center
6/01/2015 07:20:00 PM
The cherry tree and iART building
The initial interview:
http://taiwanivfsfc.blogspot.tw/p/ivf_24.html
Individualized COS for Stimulation:
Manual Injection:
http://taiwanivfsfc.blogspot.tw/2015/10/how-to-do-injections-for-ovarian.html
Procedure:
http://taiwanivfsfc.blogspot.tw/2014/11/individual-program-design-step-1.html
Long-acting rFSH:
http://taiwanivfsfc.blogspot.tw/2014/04/assessment-of-corifollitropin-alfa-for.html
Advanced ART techniques:
MESA/TESE:
http://taiwanivfsfc.blogspot.tw/2015/09/are-you-afraid-of-testicular-sperm.html
ICSI:
http://taiwanivfsfc.blogspot.tw/2014/01/should-i-use-intracytoplasmic-sperm.html
http://taiwanivfsfc.blogspot.tw/2013/11/sperm-recipient-program-procedure.html
Embryo culture:
http://taiwanivfsfc.blogspot.tw/2010/02/lab-touring-personal-incubator.html
http://taiwanivfsfc.blogspot.tw/2013/08/experience-of-blastocyst-culture-in-dry.html
Reproductive genetics:
PGS: (for chromosomal aneuploidy screening)
http://taiwanivfsfc.blogspot.tw/2014/01/to-make-choosing-embryo-easier-array.html
http://taiwanivfsfc.blogspot.tw/2015/07/lab-touring-pgs-preimplantation-genetic.html
PGD: (for genetic disease diagnosis)
http://taiwanivfsfc.blogspot.tw/2010/02/lab-touring-pgd-preimplantation-genetic.html
http://taiwanivfsfc.blogspot.tw/2013/08/first-successful-pregnancy-after.html
Personalized embryo transfer:
ERA: (for repeated failure caused by endometrium asynchrony)
http://taiwanivfsfc.blogspot.tw/2017/02/endometrial-receptivity-array-era.html
AHA:
http://taiwanivfsfc.blogspot.tw/2010/02/lab-touring-assisted-hatching.html
FER:
http://taiwanivfsfc.blogspot.tw/2010/02/lab-touring-vitrification.html
http://taiwanivfsfc.blogspot.tw/2013/08/comparison-of-obstetric-outcome-between.html
Embryo transfer:
http://taiwanivfsfc.blogspot.tw/2010/02/lab-touring-embryo-glue.html
Sheryl Sandberg Explains Why Facebook Covers Egg-Freezing
4/27/2015 07:47:00 PM
Original Article: http://time.com/3835233/sheryl-sandberg-explains-why-facebook-covers-egg-freezing/
Sheryl Sandberg:
She is an American technology executive, activist, and author. She is the Chief Operating Officer of Facebook. In June 2012, she was elected to the board of directors by the existing board members becoming the first woman to serve on Facebook's board. Before Facebook, Sandberg was Vice President of Global Online Sales and Operations at Google, and was involved in launching Google's philanthropic arm Google.org. Before Google, Sandberg served as chief of staff for the United States Secretary of the Treasury.
In 2012 she was named in the Time 100, an annual list of the 100 most influential people in the world according to Time magazine. As of January 2014, Sandberg is reported to be worth over US$1 billion, due to her stock holdings in Facebook and other companies.
by Charlotte Alter
"I talked about it with our head of HR, and said, 'God we should cover this'"
A Facebook employee with cancer inspired COO Sheryl Sandberg to create the company’s controversial egg-freezing policy, Sandberg said in an interview released Friday.
In a Bloomberg Television interview with Emily Chang, Sandberg explained the genesis of the policy that gives employees money to get their eggs frozen in order to delay childbirth.
“There’s a young woman working at Facebook who had got cancer, and I knew her and she came to me and said, ‘I’m going to go through the treatment, and that means I won’t be able to have children unless I can freeze my eggs, and I can’t afford it, but our medical care doesn’t cover it,'” Sandberg explained. “I talked about it with our head of HR, and said, ‘God we should cover this.’ And then we looked at each other and said, ‘Why would we only cover this for women with cancer, why wouldn’t we cover this more broadly?'”
Egg-freezing has been widely used to help women with cancer preserve their fertility after chemotherapy, but it’s increasingly being used by women who want to delay motherhood for non-medical reasons, like if they haven’t found the right partner or they want to focus on work. When Facebook and Apple announced in November that they would cover elective egg-freezing for their employees, some critics attacked the policies, saying the companies were essentially encouraging women to delay motherhood until it’s convenient for the company.
Virgin CEO Richard Branson doesn’t agree. “We at Virgin want to steal the idea and offer it to our women,” he told Bloomberg in the same interview. “Somebody said to me they got criticism…and I said, ‘How can anybody criticize them for doing that? It’s women’s choice.”
He has a personal reason for supporting egg-freezing policies. “My daughter just had two wonderful twins from eggs, and they wouldn’t be here today if it weren’t for the eggs,” he said.
"I talked about it with our head of HR, and said, 'God we should cover this'"
A Facebook employee with cancer inspired COO Sheryl Sandberg to create the company’s controversial egg-freezing policy, Sandberg said in an interview released Friday.
In a Bloomberg Television interview with Emily Chang, Sandberg explained the genesis of the policy that gives employees money to get their eggs frozen in order to delay childbirth.
“There’s a young woman working at Facebook who had got cancer, and I knew her and she came to me and said, ‘I’m going to go through the treatment, and that means I won’t be able to have children unless I can freeze my eggs, and I can’t afford it, but our medical care doesn’t cover it,'” Sandberg explained. “I talked about it with our head of HR, and said, ‘God we should cover this.’ And then we looked at each other and said, ‘Why would we only cover this for women with cancer, why wouldn’t we cover this more broadly?'”
Virgin CEO Richard Branson doesn’t agree. “We at Virgin want to steal the idea and offer it to our women,” he told Bloomberg in the same interview. “Somebody said to me they got criticism…and I said, ‘How can anybody criticize them for doing that? It’s women’s choice.”
He has a personal reason for supporting egg-freezing policies. “My daughter just had two wonderful twins from eggs, and they wouldn’t be here today if it weren’t for the eggs,” he said.
She is an American technology executive, activist, and author. She is the Chief Operating Officer of Facebook. In June 2012, she was elected to the board of directors by the existing board members becoming the first woman to serve on Facebook's board. Before Facebook, Sandberg was Vice President of Global Online Sales and Operations at Google, and was involved in launching Google's philanthropic arm Google.org. Before Google, Sandberg served as chief of staff for the United States Secretary of the Treasury.
In 2012 she was named in the Time 100, an annual list of the 100 most influential people in the world according to Time magazine. As of January 2014, Sandberg is reported to be worth over US$1 billion, due to her stock holdings in Facebook and other companies.